Ping Lin

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 7

Top Topics

Transforming Growth Factor

Signaling Pathway

Ejection Fraction

Top Venues

Cell death & disease

Signal transduction and targeted therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Gang Zhao, Qijing Wang, Yue Zhang, Rui Gu, Min Liu, Qin Li, Jie Zhang, Hang Yuan, Tianyu Feng, Deqiong Ou, Siqi Li, Shan Li, Kai Li, Chun-Fen Mo, Ping Lin
DDX17 induces epithelial-mesenchymal transition and metastasis through the miR-149-3p/CYBRD1 pathway in colorectal cancer. Cell death & disease 14 (1) (2023)
Gang Zhao, Qijing Wang, Yue Zhang, Rui Gu, Min Liu, Qin Li, Jie Zhang, Hang Yuan, Tianyu Feng, Deqiong Ou, Siqi Li, Shan Li, Kai Li, Chun-Fen Mo, Ping Lin
DDX17 induces epithelial-mesenchymal transition and metastasis through the miR-149-3p/CYBRD1 pathway in colorectal cancer. Cell death & disease 14 (1) (2023)
Gang Zhao, Qijing Wang, Yue Zhang, Rui Gu, Min Liu, Qin Li, Jie Zhang, Hang Yuan, Tianyu Feng, Deqiong Ou, Siqi Li, Shan Li, Kai Li, Chun-Fen Mo, Ping Lin
DDX17 induces epithelial-mesenchymal transition and metastasis through the miR-149-3p/CYBRD1 pathway in colorectal cancer. Cell death & disease 14 (1) (2023)
Gang Zhao, Qijing Wang, Yue Zhang, Rui Gu, Min Liu, Qin Li, Jie Zhang, Hang Yuan, Tianyu Feng, Deqiong Ou, Siqi Li, Shan Li, Kai Li, Chun-Fen Mo, Ping Lin
DDX17 induces epithelial-mesenchymal transition and metastasis through the miR-149-3p/CYBRD1 pathway in colorectal cancer. Cell death & disease 14 (1) (2023)
Gang Zhao, Qijing Wang, Yue Zhang, Rui Gu, Min Liu, Qin Li, Jie Zhang, Hang Yuan, Tianyu Feng, Deqiong Ou, Siqi Li, Shan Li, Kai Li, Chun-Fen Mo, Ping Lin
DDX17 induces epithelial-mesenchymal transition and metastasis through the miR-149-3p/CYBRD1 pathway in colorectal cancer. Cell death & disease 14 (1) (2023)
Gang Zhao, Hang Yuan, Qin Li, Jie Zhang, Yafei Guo, Tianyu Feng, Rui Gu, Deqiong Ou, Siqi Li, Kai Li, Ping Lin
DDX39B drives colorectal cancer progression by promoting the stability and nuclear translocation of PKM2. Signal transduction and targeted therapy 7 (1) (2022)
Yafei Guo, Qin Li, Gang Zhao, Jie Zhang, Hang Yuan, Tianyu Feng, Deqiong Ou, Rui Gu, Siqi Li, Kai Li, Ping Lin
Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53. Cell death & disease 12 (10) (2021)